Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.76−0.25 (-12.44%)
Close on Nov 20, 2026Market cap $104.25MP/E –Yield –
Adagene free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$15.67M. The highest annual figure on record is -$14.78M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.67M | – |
| FY2024 | Dec 31, 2024 | -$29.73M | – |
| FY2023 | Dec 31, 2023 | -$28.54M | – |
| FY2022 | Dec 31, 2022 | -$49.30M | – |
| FY2021 | Dec 31, 2021 | -$45.92M | – |
| FY2020 | Dec 31, 2020 | -$29.46M | – |
| FY2019 | Dec 31, 2019 | -$18.31M | – |
| FY2018 | Dec 31, 2018 | -$14.78M | – |
See a number that looks wrong?